期刊文献+

Mcl-1与高尔基体磷酸化蛋白在结肠癌组织中的表达及与其临床病理特征的关系 被引量:4

Expression of Myeloid Leukemia-1 (Mcl-1) and Golgi Phosphor Protein (Golph3) in Colon Carcinoma and Its Relationship with Clinical Pathological Features
下载PDF
导出
摘要 目的探究髓细胞白血病-1(Mcl-1)与高尔基体磷酸化蛋白(Golph3)在结肠癌组织中的表达水平及与其临床病理特征的关系。方法应用免疫组化方法,检测60例结肠癌组织中Mcl-1、Golph3表达水平,并与其癌旁正常组织中的表达水平进行比较。结果 Golph3、Mcl-1在正常组织及结肠癌组织中均有表达,然而在结肠癌组织中的阳性表达率显著高于癌旁正常组织(P<0.05);Mcl-1表达水平与患者性别、年龄、肿瘤分化程度、淋巴结转移无明显相关性(P>0.05),与肿瘤浸润深度、临床分期密切相关,浸润程度大,临床分期Ⅲ、Ⅳ期结肠癌组织中Mcl-1阳性表达率显著较高(P<0.05);Golph3水平与浸润深度、淋巴结转移密切相关,浸润程度大,发生淋巴结转移患者组织中Golph3阳性表达率明显较高(P<0.05)。结论 Mcl-1、Golph3参与结肠癌的发生、发展过程中,与正常组织相比其表达量显著升高,且与肿瘤远端转移、淋巴结转移,临床分期等病理参数密切相关。 Objective To investigate the expression of myeloid leukemia-1( Mcl-1) and Golgi phosphor protein( Golph3) in colon carcinoma and its relationship with clinical pathological features. Methods The expression level of Mcl-1 and Golph3 in 60 cases of colon cancer tissues were detected using immunohistochemical method,and compared with adjacent normal tissues. Results Mcl-1 and Golph3 in normal tissues and colorectal cancer tissues were expressed,but in colon cancer tissues the positive expression was significantly higher than normal tissues( P〈0. 05); there was no significant difference between the expression level of Mcl-1 in patients and gender,age,tumor differentiation,lymph node metastasis( P〉0. 05). But the expression level of Mcl-1 in patients was closely related to the clinical stage,the depth of tumor invasion. The positive expression rate of Mcl-1 in colon cancer with clinical stage Ⅲ,Ⅳ and depth of tumor invasion was significantly higher( P〈0. 05). The expression level of Golph3 was related to infiltration depth and lymph node metastasis,while Golph3 has significantly higher expression in lymph node metastasis tissues and the large degree of invasion( P〈0. 05). Conclusion Mcl-1,Golph3 are involved in the process of development colon cancer,and the expression significantly increased compared with the normal tissue,which are related to distal metastasis tumor,lymph node metastasis,clinical stage,pathology the parameters.
出处 《实用癌症杂志》 2017年第9期1420-1422,1426,共4页 The Practical Journal of Cancer
关键词 结肠癌 MCL-1 Golph3 免疫组化 临床病理 Colon carcinoma Myeloid leukemia-1(Mcl-1) Golgi phosphor protein(Golph3) Immunohistochemical Clinical pathological
  • 相关文献

参考文献5

二级参考文献75

  • 1任镜清,周志伟,万德森,卢震海,陈功,王国强,唐绍贤,王俊江.结肠癌根治术后复发转移的单因素和多因素分析[J].癌症,2006,25(5):591-595. 被引量:33
  • 2赵东兵,高纪东,单毅,周志祥,袁兴华,吴健雄,邵永孚.结肠癌根治术后转移复发的特点及预后分析[J].中华胃肠外科杂志,2006,9(4):291-293. 被引量:36
  • 3徐祗永,刘瑞林,李鹏,吴兴美.36例结肠癌术后复发临床分析[J].实用医技杂志,2007,14(4):490-491. 被引量:4
  • 4Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer[J]. N Engl J Med, 2004, 350(23): 2343-2351.
  • 5de Gramont A, Boni C, Navarro M, et al. Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC triM, inclliding survival, with a median follow-up of six years[J]. J Clin Oncol, 2007, 25(18S): 4007a.
  • 6Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage Ⅱ and Ⅲ colon cancer: results from NSABP c-07[J].J Clin Oncol, 2007, 25(16): 2198-2204.
  • 7Wolmark N, Wieand S, Kuebler PJ, et al. A phase Ⅲ trial comparing FULV to FULV + oxaliplatin ha stage Ⅱ or Ⅲ carcinoma of the colon: Survival results of NSABP Protocol c-07[J].J Clin Oncol, 2008, 26(15S): LBA4005a.
  • 8Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma[J].N Engl J Med, 1990, 322(6): 352-358.
  • 9Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic[J]. J Clin Oncol, 1989, 7(10): 1447-1456.
  • 10Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage Ⅲ colon carcinoma: a final report[J]. Ann Intern Med, 1995, 122(5): 321-326.

共引文献465

同被引文献22

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部